Pattern and prognostic factors in patients with malignant ascites: a retrospective study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Runyon, B. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402033300508 · Cited by 452
Ascitic fluid analysis in malignancy-related ascites
Runyon, B. A., Hoefs, J. C., & Morgan, T. R. (1988) · Hepatology · doi:10.1002/hep.1840080521 · Cited by 361
Byrne, A. T., Ross, L. H., Holash, J., Nakanishi, M., Hu, L., Hofmann, J., Yancopoulos, G. D., & Jaffe, R. B. (2003) · PubMed · Cited by 310
Malignant Ascites: Clinical and Experimental Observations
GARRISON, R. N., KAELIN, L. D., HEUSER, L. S., & GALLOWAY, R. H. (1986) · Annals of Surgery · doi:10.1097/00000658-198606000-00009 · Cited by 208
Malignant ascites: a 2-year review from a teaching hospital
Parsons, S. L., Lang, M. W., & Steele, R. J. (1996) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(96)80009-6 · Cited by 124
Self-citationImmunotherapy of malignant ascites with trifunctional antibodies
Heiss, M. M., Ströhlein, M. A., Jäger, M., Kimmig, R., Burges, A., Schoberth, A., Jauch, K., Schildberg, F., & Lindhofer, H. (2005) · International Journal of Cancer · doi:10.1002/ijc.21165 · Cited by 117
Malignant ascites: demographics, therapeutic efficacy and predictors of survival.
Mackey, J. R., & Venner, P. M. (1996) · PubMed · Cited by 67
Marmé, A., Strauß, G., Bastert, G., Grischke, E., & Moldenhauer, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10562 · Cited by 58
Change in symptoms after paracentesis for symptomatic malignant ascites
Easson, A. M., Bezjak, A., Ross, S., Sam, F., Newman, A., Bana, N., & Wright, J. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.6071 · Cited by 6
Cited by
Dai, S., Wei, D., Wu, Z., Zhou, X., Wei, X., Huang, H., & Li, G. (2008) · Molecular Therapy · doi:10.1038/mt.2008.1 · Cited by 805
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Kipps, E., Tan, D. S. P., & Kaye, S. B. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3432 · Cited by 562
Heiss, M. M., Murawa, P., Koralewski, P., Kutarska, E., Kolesnik, O. O., Ivanchenko, V. V., Dudnichenko, A. S., Aleknaviciene, B., Razbadauskas, A., Gore, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25423 · Cited by 549
Self-citationAhmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures
Sangisetty, S. L. (2012) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v4.i4.87 · Cited by 288
Seimetz, D., Lindhofer, H., & Bokemeyer, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.03.001 · Cited by 284
Catumaxomab: Clinical development and future directions
Linke, R., Klein, A., & Seimetz, D. (2010) · mAbs · doi:10.4161/mabs.2.2.11221 · Cited by 274
“Common symptoms are increase of abdominal girth, abdominal pain, anorexia, nausea and vomiting.(10) At present, there exist no evidence-based guidelines for the evaluation and treatment of malignant ascites.”
The Untapped Potential of Ascites in Ovarian Cancer Research and Treatment
Ford, C. E., Werner, B., Hacker, N. F., & Warton, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0875-x · Cited by 261
Cai, J., Tang, H., Xu, L., Wang, X., Yang, C., Ruan, S., Guo, J., Hu, S., & Wang, Z. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr230 · Cited by 173
Xu, S., Yang, Y., Dong, L., Qiu, W., Yang, L., Wang, X., & Liu, L. (2014) · Scientific Reports · doi:10.1038/srep05646 · Cited by 50
Rethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids
Neoh, K. H., Hassan, A. A., Chen, A., Sun, Y., Liu, P., Xu, K.-F., Wong, A. S. T., & Han, R. P. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.006 · Cited by 44
“Malignant ascites refers to excess accumulation of fluid in the peritoneal cavity accompanied with presence of tumor cells [4,5].”
Background
Metadata
- Authors
- Ayantunde, A. A., & Parsons, S. L.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 18
- Issue
- 5
- Pages
- 945-949
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2121080406
- Cited by
- 385
- References
- 9
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.